← Leaderboards
Zheng-Sheng J Ye
Sloan-Kettering Institute For Cancer Res
$464,700
Attributed
$464,700
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$464,700 · 1
By mechanism
K08$464,700 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Kenneth J Marians$27,560,768
- Jerard Hurwitz$13,782,007
- Pier Paolo Pandolfi$54,825,346
- Dinshaw J Patel$22,114,307
- Stewart H Shuman$39,945,088
Others in their field
Top investigators on “Neoplasm /Cancer Therapy”
- Charles A Coltman · Southwest Oncology Group$171,715,324
- Gregory H Reaman · National Childhood Cancer Foundation$143,691,240
- Norman Wolmark · Nsabp Foundation, Inc.$130,339,857
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Bruce J Hillman · American College Of Radiology$89,322,170
- Philip J Disaia · University Of California Irvine$47,533,330
Research focus
Neoplasm /Cancer TherapyCell CycleCell Growth RegulationCell SenescenceChromosomesDna ReplicationEnzyme ActivityEnzyme InhibitorsImmunoprecipitationNeoplastic GrowthProtein Protein InteractionProtein Structure FunctionTelomereTransfectionWestern BlottingsApoptosisYeast Two Hybrid System
Grant awards (5)
Model for Targeting Tankyrase1 in Cancer Therapy$132,840
K08 · FY2005 · CA
Model for Targeting Tankyrase1 in Cancer Therapy$113,400
K08 · FY2004 · CA
Model for Targeting Tankyrase1 in Cancer Therapy$19,440
K08 · FY2004 · CA
Model for Targeting Tankyrase1 in Cancer Therapy$132,840
K08 · FY2003 · CA
Model for Targeting Tankyrase1 in Cancer Therapy$66,180
K08 · FY2002 · CA